Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetic, and Food Effects of ARD-885 Film-coated Tablets in Healthy Chinese Subjects and Patients With Rheumatoid Arthritis
Clinical trial NCT07266207 · COMPLETED
Trial details
- NCT number
- NCT07266207
- Sponsor
- Artivila (Shenzhen) Innovation Center, Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2025-08-14
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.